In the second part of his Pharma Commerce video interview, Franco Stevanato, CEO of Stevanato Group, describes how from FDA ...

Pharma giant AbbVie reveals plans to expand its presence in the obesity drug market through pipeline development and ...

On Thursday, Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH) reported fourth-quarter adjusted EPS of 92 cents, up from 88 cents a year ago, but missing the consensus of 94 cents. Amphastar is a ...

Amneal Pharmaceuticals (NYSE:NASDAQ:AMRX), a commercial-stage biopharmaceutical company with a market capitalization of $2.53 billion, has been positioning itself for a new phase of multi-year growth ...

ST LOUIS--(BUSINESS WIRE)--Particle Dynamics, a leader in oral solid dosage (OSD) technologies for the pharmaceutical sector, has announced the appointment of industry veteran Mark Bolling as its new ...

Stressing the need for the restoration of Weighted R&D Deduction (up to 200%), he noted that it would significantly boost ...

The pharmaceutical industry is experiencing a profound transformation in how it approaches commercial decision-making and insights delivery with a big wave of technology and AI at the doorstep. Market ...

Biomarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best biotech stocks to buy according to Wall Street analysts. On November 18, BioMarin Pharmaceutical (NASDAQ:BMRN) presented at the Jefferies ...

Companies are facing a situation where they need to fill their pipelines, but also navigate a competitive environment for the ...

The year also reinforced a long-standing strength of Indian pharma: its ability to scale through strategic consolidation. Over the past decade, Indian drugmakers have pursued selective, high-impact ...